Natrecor Safety Confirmed In ADHERE Heart Failure Registry, J&J Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Johnson & Johnson defends safety of nesiritide, says hospital registry shows Natrecor is associated with significantly lower mortality rate than milrinone or dobutamine, and a rate equivalent to that of nitroglycerin.